Enhancement of cisplatin-mediated cytotoxicity and apoptosis against bladder cancer cells in vitro and in vivo by the selective cyclooxygenase-2 inhibitor

被引：0
|
作者：
Mizutani, Y
Li, YN
Shiraishi, T
Nakamura, T
Nomoto, T
Okihara, K
Ukimura, O
Yoneda, K
Kawauchi, A
Miki, T
机构：
来源：
JOURNAL OF UROLOGY | 2006年 / 175卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)32891-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
645
引用
收藏
页码：207 / 208
页数：2
相关论文
共 50 条
  • [1] Enhanced cisplatin-mediated cytotoxicity and apoptosis against bladder cancer cells in vitro and in vivo by the selective cyclooxygenase-2 inhibitor.
    Mizutani, Yoichi
    Li, Yong Nan
    Shiraishi, Takumi
    Nakamura, Terukazu
    Nomoto, Takeshi
    Okihara, Koji
    Ukimura, Osamu
    Yoneda, Kimihiko
    Kawauchi, Akihiro
    Miki, Tsuneharu
    CANCER RESEARCH, 2006, 66 (08)
  • [2] Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522
    Mizutani, Y
    Nakanishi, H
    Li, YN
    Sato, N
    Kawauchi, A
    Miki, T
    JOURNAL OF UROLOGY, 2004, 172 (04): : 1474 - 1479
  • [3] Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer
    Mizutani, Y
    Kamoi, K
    Ukimura, O
    Kawauchi, A
    Miki, T
    JOURNAL OF UROLOGY, 2002, 168 (06): : 2650 - 2654
  • [4] Effects of a selective cyclooxygenase-2 inhibitor on cancer cells in vitro
    Fife, RS
    Stott, B
    Carr, RE
    CANCER BIOLOGY & THERAPY, 2004, 3 (02) : 228 - 232
  • [5] Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, in combination with 5-fluorouracil against bladder cancer
    Mizutani, Y
    Nakanishi, H
    Li, Y
    Matsubara, H
    Nomoto, T
    Nakao, M
    Miki, T
    JOURNAL OF UROLOGY, 2003, 169 (04): : 137 - 137
  • [6] Enhancement of the Sensitivity of Renal Cell Carcinoma Cells to Fas-Mediated Cytotoxicity and Apoptosis by the Selective Cyclooxygenase-2 Inhibitor JTE-522
    Sato, Nodoka
    Mizutani, Yoichi
    Li, Yong Nan
    Fujiwara, Jun
    Ishida, Hirokazu
    Toiyama, Daisuke
    Abe, Koichi
    Hayashi, Issei
    Nakanishi, Hiroyuki
    Kawauchi, Akihiro
    Miki, Tsuneharu
    UROLOGIA INTERNATIONALIS, 2010, 84 (03) : 362 - 368
  • [7] Combination chemotherapy with JTE-522, a novel selective cyclooxygenase-2 inhibitor, and cisplatin against gastric cancer cell lines in vitro and in vivo
    Sugiura, T
    Saikawa, Y
    Kubota, T
    Suganuma, K
    Otani, Y
    Watanabe, M
    Kumai, K
    Kitajima, M
    IN VIVO, 2003, 17 (03): : 229 - 233
  • [8] Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
    Zhi-Jun Dai
    Xiao-Bin Ma
    Hua-Feng Kang
    Jie Gao
    Wei-Li Min
    Hai-Tao Guan
    Yan Diao
    Wang-Feng Lu
    Xi-Jing Wang
    Cancer Cell International, 12
  • [9] Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
    Dai, Zhi-Jun
    Ma, Xiao-Bin
    Kang, Hua-Feng
    Gao, Jie
    Min, Wei-Li
    Guan, Hai-Tao
    Diao, Yan
    Lu, Wang-Feng
    Wang, Xi-Jing
    CANCER CELL INTERNATIONAL, 2012, 12
  • [10] A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2
    Pyo, H
    Choy, H
    Amorino, GP
    Kim, JS
    Cao, QW
    Hercules, SK
    DuBois, RN
    CLINICAL CANCER RESEARCH, 2001, 7 (10) : 2998 - 3005
12345